Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study | Zendy

Charles Béguelin | Zendy; Nicole Friolet | Zendy; Darius Moradpour | Zendy; Roland Sahli | Zendy; Franziska SuterRiniker | Zendy; Alexander U. Lüthi | Zendy; Matthias Cavassini | Zendy; Huldrych F. Günthard | Zendy; Manuel Battegay | Zendy; Enos Bernasconi | Zendy; Patrick Schmid | Zendy; Alexandra Calmy | Zendy; Andrew Atkinson | Zendy; Andri Rauch | Zendy; Gilles Wandeler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study

Author(s) -

Charles Béguelin,

Nicole Friolet,

Darius Moradpour,

Roland Sahli,

Franziska SuterRiniker,

Alexander U. Lüthi,

Matthias Cavassini,

Huldrych F. Günthard,

Manuel Battegay,

Enos Bernasconi,

Patrick Schmid,

Alexandra Calmy,

Andrew Atkinson,

Andri Rauch,

Gilles Wandeler

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix125

Subject(s) - virology , medicine , hepatitis delta , hepatitis d virus , virus , viral disease , hepatitis d , sida , cohort , hepatitis b virus , hepatitis c virus , hbsag

We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research